These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6696005

  • 1. The effects of pregnancy on patients with hyperprolactinemia.
    Samaan NA, Leavens ME, Sacca R, Smith K, Schultz PN.
    Am J Obstet Gynecol; 1984 Feb 15; 148(4):466-73. PubMed ID: 6696005
    [Abstract] [Full Text] [Related]

  • 2. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M, Rydner T, Carlström K.
    Acta Obstet Gynecol Scand; 1980 Feb 15; 59(2):137-41. PubMed ID: 6773290
    [Abstract] [Full Text] [Related]

  • 3. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG, Prescott RW, Kendall-Taylor P, Hall K, Crombie AL, Hall R, McGregor A, Watson MJ, Cook DB.
    Am J Med; 1983 Nov 15; 75(5):868-74. PubMed ID: 6638052
    [Abstract] [Full Text] [Related]

  • 4. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E, Schivardi MR, Falsetti L, Gastaldi A.
    Minerva Ginecol; 1989 Mar 15; 41(3):157-60. PubMed ID: 2666885
    [Abstract] [Full Text] [Related]

  • 5. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ.
    Acta Eur Fertil; 1984 Mar 15; 15(2):83-91. PubMed ID: 6475464
    [Abstract] [Full Text] [Related]

  • 6. Normal and abnormal prolactin levels during human pregnancy. Lack of influence on fetoplacental endocrine function.
    Andersen AN, Pedersen H, Westergaard JG, Schiøler V, Arends J.
    Acta Obstet Gynecol Scand; 1984 Mar 15; 63(2):145-8. PubMed ID: 6730928
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH.
    Int J Fertil; 1986 Mar 15; 31(1):67-70. PubMed ID: 2908279
    [Abstract] [Full Text] [Related]

  • 8. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L, Roggia A, Loda G, Turla R, Scagliola T, Schimberni M, Pontiroli AE.
    Horm Metab Res; 1983 Aug 15; 15(8):380-4. PubMed ID: 6618428
    [Abstract] [Full Text] [Related]

  • 9. [Persisting suppression of hyperprolactinemia after bromcriptine withdrawal].
    Drobnjak P, Simunić V, Puharić I, Suchanek E.
    Jugosl Ginekol Opstet; 1982 Aug 15; 22(1-2):31-4. PubMed ID: 7132424
    [Abstract] [Full Text] [Related]

  • 10. Decrease in serum prolactin during bromocriptine-induced pregnancy and subsequent restoration of reproductive function in some hyperprolactinemic women.
    Seki K, Kato K.
    Endocrinol Jpn; 1987 Oct 15; 34(5):701-7. PubMed ID: 3436300
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy after treatment in patients with prolactinoma: operation versus bromocriptine.
    Samaan NA, Schultz PN, Leavens TA, Leavens ME, Lee YY.
    Am J Obstet Gynecol; 1986 Dec 15; 155(6):1300-5. PubMed ID: 3789042
    [Abstract] [Full Text] [Related]

  • 12. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C, Telloli P, Rampini P, Caldara R.
    Gynecol Obstet Invest; 1980 Dec 15; 11(6):317-26. PubMed ID: 6785158
    [Abstract] [Full Text] [Related]

  • 13. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K, Minato K, Ikeno N, Watanabe M, Endo H, Yamamoto H.
    Am J Obstet Gynecol; 1983 May 01; 146(1):74-9. PubMed ID: 6405619
    [Abstract] [Full Text] [Related]

  • 14. Treatment of patients with prolactinomas.
    Werder Kv, Fahlbusch R, Landgraf R, Pickardt CR, Rjosk HK, Scriba PC.
    J Endocrinol Invest; 1978 Jan 01; 1(1):47-58. PubMed ID: 755842
    [Abstract] [Full Text] [Related]

  • 15. [Sterility in hyperprolactinemic amenorrhea].
    Tscherne G, Urdl W.
    Zentralbl Gynakol; 1983 Jan 01; 105(8):478-81. PubMed ID: 6868876
    [Abstract] [Full Text] [Related]

  • 16. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW, Seldenrath HJ, Kwa HG, Birkenhäger JC.
    J Clin Endocrinol Metab; 1977 Jan 01; 44(1):180-4. PubMed ID: 576229
    [Abstract] [Full Text] [Related]

  • 17. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S, Murray MA, Jequier AM, Steele SJ, Nabarro JD, Jacobs HS.
    Clin Endocrinol (Oxf); 1975 Nov 01; 4(6):597-607. PubMed ID: 1104218
    [Abstract] [Full Text] [Related]

  • 18. [Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
    Melzer H, Uhlmann G.
    Zentralbl Gynakol; 1985 Nov 01; 107(16):989-95. PubMed ID: 3931388
    [Abstract] [Full Text] [Related]

  • 19. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP, Stone SC.
    Obstet Gynecol; 1976 Jul 01; 48(1):84-9. PubMed ID: 934580
    [Abstract] [Full Text] [Related]

  • 20. Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas.
    Faria MA, Tindall GT.
    J Neurosurg; 1982 Jan 01; 56(1):33-43. PubMed ID: 7198681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.